These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9467917

  • 21. Susceptibilities of 97 strains of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
    Ismaeel NA.
    Microbios; 1997; 91(367):97-103. PubMed ID: 9467924
    [Abstract] [Full Text] [Related]

  • 22. [Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
    Barcelona L, Marín M, Stamboulian D.
    Medicina (B Aires); 2008; 68(1):65-74. PubMed ID: 18416324
    [Abstract] [Full Text] [Related]

  • 23. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH, Chan KC, Liu HB, Chung WH, Leung YC, Wong KY.
    Anal Chem; 2005 Aug 15; 77(16):5268-76. PubMed ID: 16097768
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Sulbactam-containing beta-lactamase inhibitor combinations.
    Akova M.
    Clin Microbiol Infect; 2008 Jan 15; 14 Suppl 1():185-8. PubMed ID: 18154545
    [Abstract] [Full Text] [Related]

  • 28. beta-Lactam resistance phenotype determination in Escherichia coli isolates from University Malaya Medical Centre.
    Wong JS, Mohd Azri ZA, Subramaniam G, Ho SE, Palasubramaniam S, Navaratnam P.
    Malays J Pathol; 2003 Dec 15; 25(2):113-9. PubMed ID: 16196367
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors.
    Coleman K.
    Curr Opin Microbiol; 2011 Oct 15; 14(5):550-5. PubMed ID: 21840248
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The beta-lactamase problem: new therapeutic options.
    Schito GC, Pesce A, Debbia EA, Marchese A.
    J Chemother; 1995 May 15; 7 Suppl 1():5-8. PubMed ID: 8618111
    [Abstract] [Full Text] [Related]

  • 35. β-lactam/β-lactamase inhibitor combinations: from then to now.
    Toussaint KA, Gallagher JC.
    Ann Pharmacother; 2015 Jan 15; 49(1):86-98. PubMed ID: 25361682
    [Abstract] [Full Text] [Related]

  • 36. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
    Swarén P, Golemi D, Cabantous S, Bulychev A, Maveyraud L, Mobashery S, Samama JP.
    Biochemistry; 1999 Jul 27; 38(30):9570-6. PubMed ID: 10423234
    [Abstract] [Full Text] [Related]

  • 37. Beta-lactam antibiotics and mycobacteria.
    Finch R.
    J Antimicrob Chemother; 1986 Jul 27; 18(1):6-8. PubMed ID: 3093446
    [No Abstract] [Full Text] [Related]

  • 38. Distribution and characterization of beta-lactamases of mycobacteria and related organisms.
    Kwon HH, Tomioka H, Saito H.
    Tuber Lung Dis; 1995 Apr 27; 76(2):141-8. PubMed ID: 7780097
    [Abstract] [Full Text] [Related]

  • 39. Contribution of beta-lactamase production to the resistance of mycobacteria to beta-lactam antibiotics.
    Quinting B, Reyrat JM, Monnaie D, Amicosante G, Pelicic V, Gicquel B, Frère JM, Galleni M.
    FEBS Lett; 1997 Apr 14; 406(3):275-8. PubMed ID: 9136901
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.